Vasconcelles Michael
SEC-identified person · CIK 1734755 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Zeta Acquisition Corp III KURO | Director | filed 2024–2026 |
| Day One Biopharmaceuticals, Inc. DAWN | Head of Research and Dev. | filed 2025–2026 |
| Immunogen, Inc. IMGN | EVP R&D & MEDICAL AFFAIRS | filed 2023–2024 |
| Magenta Therapeutics, Inc. MGTA | Director | filed 2022–2022 |
| Unum Therapeutics, Inc. UNUM | Chief Medical Officer | filed 2018–2019 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.